Trial
NCT03718650
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Varian Medical Systems
Condition
Pancreatic Cancer
Intervention
Pimonidazole
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-08